Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. MASS
MASS logo

MASS Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
6.650
Open
6.060
VWAP
6.44
Vol
175.83K
Mkt Cap
177.60M
Low
6.050
Amount
1.13M
EV/EBITDA(TTM)
--
Total Shares
--
EV
139.26M
EV/OCF(TTM)
--
P/S(TTM)
3.99
908 Devices Inc. is revolutionizing chemical analysis with its simple handheld and desktop devices, addressing life-altering applications. Its devices are used at the point-of-need to interrogate unknown and invisible materials and provide actionable answers to directly address some of the critical problems in forensics, bioprocessing, pharma/biopharma, life science research and adjacent markets. Its forensics & field detection products include MX908, XplorIR, ProtectIR, ThreatID, and InterceptIR. MX908 is a handheld, battery-powered, Mass Spec device designed for the analysis of solid, liquid, vapor and aerosol materials of unknown identity. MX908 is a multi-purpose device utilized by a spectrum of user segments for a variety of forensic field applications, including chemical, explosive, priority drug and hazardous materials operations, detecting materials at the trace level. XplorIR is a handheld gas detector that can detect and quantify unknown chemicals and vapors in seconds.
Show More

Events Timeline

(ET)
2026-03-09
07:00:00
908 Devices Files $100M Mixed Securities Shelf
select
2026-03-03 (ET)
2026-03-03
07:20:00
908 Devices Reports Q4 Revenue of $17.38M
select
2026-03-03
07:20:00
908 Devices Expects 2026 Revenues of $64.5M to $67.5M
select
2026-01-20 (ET)
2026-01-20
16:20:00
Major Averages Drop as Trump Revives Tariff Threats
select
2026-01-20
12:10:00
Major Averages Broadly Lower, Gold Hits Record Highs
select
2026-01-20
07:10:00
CEO States Strong Profit Growth Expected by 2025
select
2026-01-20
07:10:00
Company Expects Revenue of Approximately $56 Million for 2025
select
2025-11-10 (ET)
2025-11-10
07:21:39
908 Devices reaffirms FY25 revenue forecast of $54M-$56M, aligning with consensus of $55.42M
select
2025-11-10
07:20:49
908 Devices announces Q3 earnings per share of 41 cents, surpassing consensus estimate of 12 cents.
select
2025-10-28 (ET)
2025-10-28
07:55:51
908 Devices reveals Coast Guard acquisition of 23 MX908 units
select

News

Newsfilter
1.0
03-16Newsfilter
908 Devices CEO to Present at Sidoti Small Cap Conference
  • Conference Details: 908 Devices' CEO Kevin J. Knopp and CFO Joe Griffith will participate in the Sidoti Small Cap Conference on March 18, 2026, starting at 1:45 p.m. Eastern Time, aimed at attracting investor interest in the company's growth trajectory.
  • Live Webcast: The event will feature a live audio webcast, allowing investors to access an archived version through the company's 'Investors' section, enhancing interaction and transparency between the company and potential investors.
  • Technological Innovation: 908 Devices focuses on developing handheld chemical analysis tools that leverage advanced analytical technologies, software automation, and machine learning to address critical health, safety, and defense issues, particularly in combating the fentanyl and illicit drug crisis.
  • Market Positioning: The company aims to provide rapid, actionable analytical results in vital health and safety applications, showcasing its strategic significance in addressing global security threats and toxic carcinogen exposure, thereby reinforcing its market leadership.
seekingalpha
9.5
03-03seekingalpha
908 Devices Q4 Earnings Exceed Expectations
  • Earnings Highlights: 908 Devices reported a GAAP EPS of $0.11 for Q4 2025, beating expectations by $0.18, which reflects a significant improvement in profitability and boosts investor confidence.
  • Revenue Growth: The company achieved Q4 revenue of $17.38 million, representing a 21.2% year-over-year increase and exceeding market expectations by $1.19 million, indicating strong market demand and sales performance in ongoing operations.
  • Positive Cash Flow: 908 Devices delivered a net income of $4.4 million from continuing operations and a positive Adjusted EBITDA of $0.7 million in Q4, successfully achieving cash flow positivity and further solidifying its financial health.
  • 2026 Guidance: The company expects full-year 2026 revenues to range between $64.5 million and $67.5 million, reflecting a 15% to 20% growth compared to 2025, surpassing the consensus of $65.38 million, demonstrating confidence in future growth prospects.
Benzinga
8.5
01-21Benzinga
Ark Invest Unveils 2026 Big Ideas, Forecasts 1.9% GDP Growth Boost
  • Technological Acceleration: Ark Invest's report highlights that capital investment in disruptive innovation platforms could contribute 1.9 percentage points to annualized real GDP growth during this decade, emphasizing the potential of technologies like robotaxis and next-gen data centers.
  • Strong ETF Performance: In 2025, Ark's Autonomous Technology & Robotics ETF and Space & Defense Innovation ETF achieved returns of 49.8% and 49.2%, respectively, showcasing the firm's ability to generate returns in emerging technology sectors.
  • Bitcoin Holdings Surge: The report indicates that U.S. ETFs and public companies now hold 12% of total Bitcoin supply, with Bitcoin ETF balances up 19.7% and public company Bitcoin holdings up 73% in 2025, reflecting strong market demand for digital assets.
  • Diverse Investment Opportunities: Ark Invest identifies several publicly traded companies, including Coinbase, Illumina, and Waymo, as key investment opportunities for the 2026 themes, indicating the firm's forward-looking approach to diversified investment strategies.
seekingalpha
9.5
01-20seekingalpha
908 Devices (MASS) Reports Q4 Revenue of $17.2M, Exceeding Expectations by 20%
  • Revenue Beat: 908 Devices reported preliminary Q4 revenue of approximately $17.2 million, exceeding consensus expectations of $15.92 million and reflecting a 20% increase from $14.3 million in Q4 2024, indicating strong performance in the U.S. state and local markets.
  • International Growth: The accelerated adoption of the VipIR product in international markets has driven sales growth, particularly to federal and defense customers, further solidifying 908 Devices' position in the industry.
  • Positive EBITDA Achievement: The company achieved positive adjusted EBITDA in Q4, marking a significant improvement in profitability and laying a solid foundation for future financial health.
  • Fiscal Year 2025 Outlook: For FY 2025, revenue is expected to be approximately $56.0 million, a 17% increase from last year, aligning with the high end of management's guidance and slightly above consensus estimates of $54.77 million, showcasing the company's growth potential.
TipRanks
5.0
2025-11-05TipRanks
Cathie Wood Increases Investment in Veracyte Before Earnings Surprise, Reduces Biotech Portfolio
  • Portfolio Adjustments: Cathie Wood's Ark Invest has reduced its holdings in several biotech companies, including 10X Genomics and Crispr Therapeutics, indicating a shift away from volatile biotech stocks towards more stable growth sectors.

  • Investment in Veracyte: Ark made a significant investment in Veracyte, purchasing over 665,690 shares, which saw a strong earnings report that exceeded expectations, leading to a 16% stock surge.

  • Roku Stake Reduction: The firm also sold more than 1.1 million shares of Roku as part of a strategy to trim its portfolio, influenced by ongoing legal issues facing the company.

  • Analyst Consensus on Veracyte: Analysts maintain a Moderate Buy consensus on Veracyte, with an average 12-month price target suggesting a potential downside from the current price, reflecting cautious optimism about the stock's future performance.

Newsfilter
6.0
2025-10-16Newsfilter
U.S. Marine Corps Acquires 908 Devices' XplorIR Gas Detection Technology
  • Purchase of XplorIR Devices: The U.S. Marine Corps CBRNE Installation and Protection Program has acquired 17 XplorIR devices from 908 Devices Inc. for the identification and quantification of hazardous gases and vapors, enhancing safety measures against CBRNE threats.

  • Capabilities of XplorIR: The handheld XplorIR device can detect and identify over 5,000 chemical threats in real-time, allowing first responders to make informed decisions while operating in hazardous environments.

Wall Street analysts forecast MASS stock price to rise
4 Analyst Rating
Wall Street analysts forecast MASS stock price to rise
3 Buy
1 Hold
0 Sell
Strong Buy
Current: 0.000
sliders
Low
6.00
Averages
6.00
High
6.00
Current: 0.000
sliders
Low
6.00
Averages
6.00
High
6.00
Leerink
Puneet Souda
Market Perform -> Outperform
upgrade
$12
AI Analysis
2025-08-05
Reason
Leerink
Puneet Souda
Price Target
$12
AI Analysis
2025-08-05
upgrade
Market Perform -> Outperform
Reason
Leerink analyst Puneet Souda upgraded 908 Devices to Outperform from Market Perform with a $12 price target.
Leerink
analyst
Market Perform
to
Outperform
upgrade
$7 -> $12
2025-08-05
Reason
Leerink
analyst
Price Target
$7 -> $12
2025-08-05
upgrade
Market Perform
to
Outperform
Reason
As previously reported, Leerink upgraded 908 Devices to Outperform from Market Perform with a price target of $12, up from $7. After the recent life science divestiture, 908 has "turned into a forensics and threat detection pure-play," says the analyst, who notes that the One Big Beautiful Act releases funds for enforcement, security, drug and broader threat detection. 908 is guiding to 15% pro-forma growth for the year, but expecting an acceleration in 2026, notes the analyst, who sees upside to the company's 20%-plus growth expectation for 2026.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for MASS
Unlock Now

Valuation Metrics

The current forward P/E ratio for 908 Devices Inc (MASS.O) is -3.02, compared to its 5-year average forward P/E of -18.00. For a more detailed relative valuation and DCF analysis to assess 908 Devices Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-18.00
Current PE
-3.02
Overvalued PE
4.41
Undervalued PE
-40.41

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-17.15
Current EV/EBITDA
-0.12
Overvalued EV/EBITDA
9.20
Undervalued EV/EBITDA
-43.49

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
8.16
Current PS
1.07
Overvalued PS
15.20
Undervalued PS
1.12

Financials

AI Analysis
Annual
Quarterly

Whales Holding MASS

A
Arch Venture Partners, L.P.
Holding
MASS
+10.68%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is 908 Devices Inc (MASS) stock price today?

The current price of MASS is 6.61 USD — it has increased 6.44

What is 908 Devices Inc (MASS)'s business?

908 Devices Inc. is revolutionizing chemical analysis with its simple handheld and desktop devices, addressing life-altering applications. Its devices are used at the point-of-need to interrogate unknown and invisible materials and provide actionable answers to directly address some of the critical problems in forensics, bioprocessing, pharma/biopharma, life science research and adjacent markets. Its forensics & field detection products include MX908, XplorIR, ProtectIR, ThreatID, and InterceptIR. MX908 is a handheld, battery-powered, Mass Spec device designed for the analysis of solid, liquid, vapor and aerosol materials of unknown identity. MX908 is a multi-purpose device utilized by a spectrum of user segments for a variety of forensic field applications, including chemical, explosive, priority drug and hazardous materials operations, detecting materials at the trace level. XplorIR is a handheld gas detector that can detect and quantify unknown chemicals and vapors in seconds.

What is the price predicton of MASS Stock?

Wall Street analysts forecast MASS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MASS is6.00 USD with a low forecast of 6.00 USD and a high forecast of 6.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is 908 Devices Inc (MASS)'s revenue for the last quarter?

908 Devices Inc revenue for the last quarter amounts to 11.78M USD, increased 58.68

What is 908 Devices Inc (MASS)'s earnings per share (EPS) for the last quarter?

908 Devices Inc. EPS for the last quarter amounts to 1.23 USD, decreased -472.73

How many employees does 908 Devices Inc (MASS). have?

908 Devices Inc (MASS) has 246 emplpoyees as of April 03 2026.

What is 908 Devices Inc (MASS) market cap?

Today MASS has the market capitalization of 177.60M USD.